FTFelix Christoph Tanner

Felix Christoph Tanner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Felix Christoph Tanner has a total of 166 co-authors. Here are the top co-authors by number of shared publications:

  • Thomas F. Lüscher

    Cardiology; University Heart Center; University Hospital Zürich; Zürich Switzerland

    14 shared publications
  • Giovanni Guido Camici

    Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; Department of Research and Education, University Hospital Zurich, Zurich, Switzerland

    13 shared publications
  • Alexander Akhmedov

    Cardiovascular Research, Institute of Physiology, University of Zurich, Zurich, Switzerland; Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland

    11 shared publications
  • Catherine Gebhard

    Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland

    10 shared publications
  • Alexander Breitenstein

    Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland

    7 shared publications
  • Barbara E. Stähli

    University Heart Center, Cardiovascular Center, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland Center of Molecular Cardiology, Schlieren Campus, University of Zurich, Zurich, Switzerland

    6 shared publications

Latest Publications

    • 1 January 2015
      • Vol. 24  (1) , 10-21

    Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.

    by Barbara E Stähli, Thi Dan Linh Nguyen-Kim, Cathérine Gebhard, Ladina Erhart, Thomas Frauenfelder, Felix C Tanner, Volkmar Falk, Ulf Landmesser, Fabian Nietlispach, Thomas F Lüscher, et al.

    The study aim was to investigate prosthesis-specific predictors for paravalvular aortic regurgitation (PAR) in self-expandable versus balloon-expandable transcatheter heart valves (THVs). PAR is frequently observed after transcatheter aortic valve replacement (TAVR). As self-expandable and balloon-expandable THVs engage differently with the native aortic valve structures, factors that impact PAR may differ between the prosthesis types. A total of 137 TAVR patients who underwent pre-procedural multidetector computed tomography and post-procedural transthoracic echocardiography were studied. Predictors for PAR, including annulus area oversizing and aortic valve calcification mass and volume, were analyzed in a multivariate model. The Medtronic CoreValve (MCV) prosthesis was utilized in 68 patients (50%), and the Edwards SAPIEN (ES) prosthesis in 69 (50%). More than mild PAR was observed in 43 patients (32%). Among MCV patients, aortic valve calcification volume and mass were higher in those with more than mild PAR than in those with none or mild PAR (p = 0.04, p = 0.03, respectively). Among ES patients, the annulus area and perimeter oversizing were lower in those with more than mild PAR compared to those with no or mild PAR (p = 0.001). By univariate and multivariate logistic regression analysis, aortic valve calcification mass was the only independent predictor for PAR in MCV patients (p = 0.02), whereas in ES patients it was THV undersizing (p = 0.002), irrespective of the calcific burden. For self-expandable THVs, aortic valve calcification mass was the strongest predictor of PAR, whereas for balloon-expandable THVs it was prosthesis undersizing. Hence, in patients evaluated for TAVR these parameters should guide the selection of prosthesis type.


  • Continuing Medical Education Activity inEchocardiography

    by Pohoey Fan, Barbara E. Stähli, Amr Abouelnour, Thi Dan Linh Nguyen, Alessandra Vecchiati, Willibald Maier, Thomas F. Lüscher, Thomas Frauenfelder, Felix C. Tanner

  • Open Access

    Alternatively Spliced Tissue Factor Is Not Sufficient for Embryonic Development

    by Susanna H. M. Sluka, Alexander Akhmedov, Johannes Vogel, Dusten Unruh, Vladimir Y. Bogdanov, Giovanni G. Camici, Thomas F. Lüscher, Wolfram Ruf, Felix C. Tanner

    Tissue factor (TF) triggers blood coagulation and is translated from two mRNA splice isoforms, encoding membrane-anchored full-length TF (flTF) and soluble alternatively-spliced TF (asTF). The complete knockout of TF in mice causes embryonic lethality associated with failure of the yolk sac vasculature. Although asTF plays roles in postnatal angiogenesis, it is unknown whether it activates coagulation sufficiently or makes previously unrecognized contributions to sustaining integrity of embryonic yolk sac vessels. Using gene knock-in into the mouse TF locus, homozygous asTF knock-in (asTFKI) mice, which express murine asTF in the absence of flTF, exhibited embryonic lethality between day 9.5 and 10.5. Day 9.5 homozygous asTFKI embryos expressed asTF protein, but no procoagulant activity was detectable in a plasma clotting assay. Although the α-smooth-muscle-actin positive mesodermal layer as well as blood islands developed similarly in day 8.5 wild-type or homozygous asTFKI embryos, erythrocytes were progressively lost from disintegrating yolk sac vessels of asTFKI embryos by day 10.5. These data show that in the absence of flTF, asTF expressed during embryonic development has no measurable procoagulant activity, does not support embryonic vessel stability by non-coagulant mechanisms, and fails to maintain a functional vasculature and embryonic survival.


  • Open Access

    Carbamylated low-density lipoprotein induces endothelial dysfunction

    by Thimoteus Speer, Frederick O. Owala, Erik W. Holy, Stephen Zewinger, Felix L. Frenzel, Barbara E. Stähli, Marjan Razavi, Sarah Triem, Hrvoje Cvija, Lucia Rohrer, et al.

    Cardiovascular events remain the leading cause of death in Western world. Atherosclerosis is the most common underlying complication driven by low-density lipoproteins (LDL) disturbing vascular integrity. Carbamylation of lysine residues, occurring primarily in the presence of chronic kidney disease (CKD), may affect functional properties of lipoproteins; however, its effect on endothelial function is unknown. Low-density lipoprotein from healthy donors was isolated and carbamylated. Vascular reactivity after treatment with native LDL (nLDL) or carbamylated LDL (cLDL) was examined in organ chambers for isometric tension recording using aortic rings of wild-type or lectin-like-oxidized LDL receptor-1 (LOX-1) transgenic mice. Reactive oxygen species (ROS) and nitric oxide (NO) production were determined using electron spin resonance spectroscopy. The effect of LDL-carbamyl-lysine levels on cardiovascular outcomes was determined in patients with CKD during a median follow-up of 4.7 years. Carbamylated LDL impaired endothelium-dependent relaxation to acetylcholine or calcium-ionophore A23187, but not endothelium-independent relaxation to sodium nitroprusside. In contrast, nLDL had no effect. Carbamylated LDL enhanced aortic ROS production by activating NADPH-oxidase. Carbamylated LDL stimulated endothelial NO synthase (eNOS) uncoupling at least partially by promoting S-glutathionylation of eNOS. Carbamylated LDL-induced endothelial dysfunction was enhanced in LOX-1 transgenic mice. In patients with CKD, LDL-carbamyl-lysine levels were significant predictors for cardiovascular events and all-cause mortality. Carbamylation of LDL induces endothelial dysfunction via LOX-1 activation and increased ROS production leading to eNOS uncoupling. This indicates a novel mechanism in the pathogenesis of atherosclerotic disease which may be pathogenic and prognostic in patients with CKD and high plasma levels of cLDL.


  • Impact of Three‐Dimensional Imaging and Pressure Recovery on Echocardiographic Evaluation of Severe Aortic Stenosis: A Pilot Study

    by Barbara E. Stähli, Amr Abouelnour, Thi Dan Linh Nguyen, Alessandra Vecchiati, Willibald Maier, Thomas F. Lüscher, Thomas Frauenfelder, Felix C. Tanner

    Aims: In patients with aortic stenosis (AS), echocardiographic grading of stenosis severity is important, in particular for transcatheter aortic valve implantation (TAVI). Three‐dimensional (3D) echocardiography and correction for pressure recovery (PR) by energy loss index (ELI) may improve aortic valve area (AVA) calculation.Methods and Results: Thirty‐nine patients with severe AS evaluated for TAVI were included. Left ventricular outflow tract (LVOT) and ascending aorta (AA) cross‐sectional area were determined in transthoracic two‐dimensional echocardiography (2DTTE), 2D transesophageal echocardiography (TEE), 3DTEE, and multislice computed tomography (MSCT). AVA was calculated by the continuity equation and corrected for PR. ELI was determined as [(AVA × AA)/(AA − AVA)]/body surface area. LVOT area was 2.41 ± 0.17 cm2 calculated using 2DTTE, 2.82 ± 0.16 cm2 calculated using 2DTEE, 3.96 ± 0.14 cm2 planimetered in 3DTEE, and 4.47 ± 0.18 cm2 planimetered in MSCT (P < 0.001). AA area was 4.62 ± 0.23 cm2 calculated using 2DTTE, 4.64 ± 0.23 cm2 calculated using 2DTEE, 5.35 ± 0.25 cm2 planimetered in 3DTEE, and 6.56 ± 0.31 cm2 planimetered in MSCT (P < 0.001). Indexed aortic valve area (AVAI) calculated by 2DTTE and 2DTEE was smaller (0.27 ± 0.02 cm2/m2 and 0.32 ± 0.02 cm2/m2) compared to 3DTEE (0.45 ± 0.02 cm2/m2; P < 0.001). When AVAI determined by 3DTEE was corrected for PR by calculation of ELI, there was a further increase (0.52 ± 0.03 cm2/m2; P < 0.001), and 10/36 (27.8%) patients were reclassified to moderate AS.Conclusion: Three‐dimensional TEE is more accurate than 2DTTE and 2DTEE for determining LVOT and AA dimensions. When AS severity is determined by 3DTEE and corrected for PR using the 3D values, it needs to be reclassified from severe to moderate in almost a third of patients.


  • Age‐ and Gender‐Dependent Left Ventricular Remodeling

    by Catherine Gebhard, Barbara E. Stähli, Caroline E. Gebhard, Hanna Tasnady, Deborah Zihler, Manfred B. Wischnewsky, Rolf Jenni, Felix C. Tanner

    Background: The effect of age and gender on left ventricular (LV) size, muscle mass, and systolic function as determined by two‐dimensional echocardiography has not yet been investigated in a large population.Methods: Normal transthoracic two‐dimensional echocardiography studies of 5307 subjects (47% males) performed between March 1990 and December 2011 were analyzed. LV end‐diastolic volume index (LVEDVI), LV muscle mass index (LVMMI), LV ejection fraction (LVEF), and LV fractional shortening (LVFS) were compared in different age groups.Results: LVMMI increased in females from 66.4 ± 1.3 g/m2 (7–20 years) to 76.3 ± 0.9 g/m2 (60–80 years; P < 0.0001) and in males from 81.9 ± 1.7 g/m2 (7–20 years) to 94.6 ± 1.3 g/m2 (60–80 years; P < 0.0001). LVEDVI decreased in females from 49.8 ± 0.9 mL/m2 (7–20 years) to 42.8 ± 0.6 mL/m2 (60–80 years; P < 0.0001) and in males from 56.6 ± 0.8 mL/m2 (7–20 years) to 49.0 ± 0.7 mL/m2 (60–80 years; P < 0.0001). A significant increase in LVEF was observed with age (P < 0.0001 for both genders), but it was more pronounced in females (62 ± 0.5% [age 7–20 years] vs. 65 ± 0.3% [age 60–80 years]) than in males (62 ± 0.5% [age 7–20 years] vs. 64 ± 0.3% [age 60–80 years]). Similarly, LVFS increased in females from 37.7 ± 0.5% (7–20 years) to 42.4 ± 0.4% (60–80 years; P < 0.001) and in males from 37.3 ± 0.5% (7–20 years) to 39.4 ± 0.5% (60–80 years; P < 0.001).Conclusions: LVEF, LVFS, and LVMMI increase with advancing age, in particular in females. In contrast, LVEDVI decreases with age. These findings indicate that the LV undergoes a lifelong remodeling.


  • Restraint stress enhances arterial thrombosisin vivo– role of the sympathetic nervous system

    by Simon F. Stämpfli, Giovanni G. Camici, Stephan Keller, Izabela Rozenberg, Margarete Arras, Beat Schuler, Max Gassmann, Irene Garcia, Thomas F. Lüscher, Felix C. Tanner

    Stress is known to correlate with the incidence of acute myocardial infarction. However, the molecular mechanisms underlying this correlation are not known. This study was designed to assess the effect of experimental stress on arterial thrombus formation, the key event in acute myocardial infarction. Mice exposed to 20 h of restraint stress displayed an increased arterial prothrombotic potential as assessed by photochemical injury-induced time to thrombotic occlusion. This increase was prevented by chemical sympathectomy performed through 6-hydroxydopamine (6-OHDA). Blood-born tissue factor (TF) activity was enhanced by stress and this increase could be prevented by 6-OHDA treatment. Vessel wall TF, platelet count, platelet aggregation, coagulation times (PT, aPTT), fibrinolytic system (t-PA and PAI-1) and tail bleeding time remained unaltered. Telemetric analysis revealed only minor hemodynamic changes throughout the stress protocol. Plasma catecholamines remained unaffected after restraint stress. Tumor necrosis factor alpha (TNF-α) plasma levels were unchanged and inhibition of TNF-α had no effect on stress-enhanced thrombosis. These results indicate that restraint stress enhances arterial thrombosis via the sympathetic nervous system. Blood-borne TF contributes, at least in part, to the observed effect whereas vessel wall TF, platelets, circulating coagulation factors, fibrinolysis and inflammation do not appear to play a role. These findings shed new light on the understanding of stress-induced cardiovascular events.


  • Open Access

    Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications

    by Barbara E. Stähli, Willibald Maier, Roberto Corti, Thomas F. Lüscher, Rolf Jenni, Felix C. Tanner

    Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications


  • Open Access

    Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure

    by Georg M. Fröhlich, Philipp Keller, Florian Schmid, Mathias Wolfrum, Martin Osranek, Christian Falk, Georg Noll, Frank Enseleit, Markus Reinthaler, Pascal Meier, et al.

    Pericardial effusion (PE) is a common finding in cardiac patients with chronic heart failure. The prognostic relevance of a small, haemodynamically non-compromising PE in such patients, however, remains to be determined. All patients referred to our heart failure clinic and having a baseline echocardiography and follow-up clinical visits were included. Patients with a haemodynamically relevant PE, acute myo-/pericarditis, systemic sclerosis, rheumatoid arthritis, heart transplantation, heart surgery within the last 6 months or malignancies within the last 3 years were excluded. Patients with or without a haemodynamically irrelevant PE were compared regarding all-cause mortality as the primary and cardiovascular death or need for heart transplantation as secondary outcomes. A total of 897 patients (824 patients in the control vs. 73 patients in the PE group) were included. In the PE group, left ventricular ejection fraction (LVEF) was lower [31%, interquartile range (IQR): 18.0–45.0] than in controls (34%, IQR: 25.0–47.0; P = 0.04), while the end-systolic diameters of the left ventricle and the left atrium were larger (P = 0.01 and P = 0.001, respectively). Similarly, in patients with PE, the right ventricle (RV) systolic function was lower (P < 0.005 for both the fractional area change and the tricuspid annulus movement), the dimensions of RV and right atrium (RA) were larger (P < 0.05 for RV and P < 0.01 for RA), and the degree of tricuspid regurgitation was higher (P < 0.0001). Furthermore, in the PE group, the heart rate was higher (P < 0.001) and the leukocyte count as well as CRP values were increased (P = 0.004 and P < 0.0001, respectively); beta-blocker use was less frequent (P = 0.04), while spironolactone use was more frequent (P = 0.03). The overall survival was reduced in the PE group compared with controls (P = 0.02). Patients with PE were more likely to suffer cardiovascular death (1-year estimated event-free survival: 86 ± 5 vs. 95 ± 1%; P = 0.01) and to require heart transplantation (1-year estimated event-free survival: 88 ± 4 vs. 95 ± 1%; P = 0.009). A multivariate Cox proportional hazard model revealed the following independent predictors of mortality: (a) PE (P = 0.04, hazard ratio (HR): 1.95, 95% confidence interval (CI): 1.0–3.7), (b) age (P = 0.04, HR: 1.02, 95% CI: 1.0–1.04) and (c) LVEF P = 0.03, HR: 1.7, 95% CI: 1.1–2.8). In chronic heart failure, even minor PEs are associated with an increased risk of all-cause mortality, cardiac death, and need for transplantation.


  • Open Access

    Caffeic Acid Phenethyl Ester Inhibits Endothelial Tissue Factor Expression

    by Cathérine Gebhard, Barbara Elisabeth Stähli, Stephanie Largiadèr, Erik Walter Holy, Alexander Akhmedov, Giovanni Guido Camici, Thomas Felix Lüscher, Felix Christoph Tanner

    Caffeic acid phenethyl ester (CAPE) is a component of honeybee hives with various beneficial properties. Tissue factor (TF), the key trigger of thrombosis, is expressed in human endothelial cells. This study was designed to investigate whether CAPE modulates TF expression in human aortic endothelial cells (HAECs). Western blots and real-time polymerase chain reactions were performed. CAPE (10−7–10−5 m) inhibited tumor necrosis factor (TNF)-α induced endothelial TF protein expression by 2.1-fold at 10−5 m (pp<0.02). In contrast, TF mRNA expression, TF promoter activity, and mitogen-activated protein (MAP) kinase activation remained unaltered. In conclusion, CAPE inhibits TF protein expression and activity at the posttranscriptional level thereby exhibiting anti-thrombotic potential.